ZORACTINE

This brand name is authorized in Nigeria.

Active ingredients

The drug ZORACTINE contains one active pharmaceutical ingredient (API):

1	Loratadine UNII 7AJO3BO7QN - LORATADINE
	Loratadine is a tricyclic antihistamine with selective, peripheral H1-receptor activity. Loratadine has no clinically significant sedative or anticholinergic properties in the majority of the population and when used at the recommended dosage.
	Read more about Loratadine

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-9205	Tablet	ZORACTINE TABLETS TAB 10 mg 10 X 10	61 RNW-PP-361448 ZORACTINE TABLETS LORATIDINE USP 10MG LORATIDINE USP 10MG EXCIPIENTS LACTOSE PB, MAIZE STARCH BP, PURIFIED WATER BP, PURIFIED TALC BP, MAGNESIUM STEARATE BP, COLLOIDIAL ANHYDROUS SILICA BP B4-9205 Drugs Imported Products 10X10 Over The Counter (OTC) 12/22/2023 ZMC INTERNATIONAL LIMITED., 7A NIGER STREET,KANO, KANO STATE, NIGERIA 576768789 zmcinternational18@gmail.com APEX FORMULATIONS PVT LTD, 1276, RAJPUR, ZULASAN ROAD, AHMEDABAD - MEHSANA HIGHWAY, DIST, MEHSANA GUJARAT, INDIA, India	28/02/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
R06AX13	Loratadine	R Respiratory system → R06 Antihistamines for systemic use → R06A Antihistamines for systemic use → R06AX Other antihistamines for systemic use
Discover more medicines within R06AX13

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-9205